Table 3.
Family history constellation | Relative risk by age at diagnosis of youngest affected relative | Absolute risk | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
All | <50 years | ≥50 years | All | Men | Women | ||||||||||||
No | SIR* (95% CI) | No | SIR* (95% CI) | No | SIR* (95% CI) | No | LCR, % (95% CI) | No | LCR, % (95% CI) | No | LCR, % (95% CI) | ||||||
0 FDR+1 SDR (excluding half siblings) | 1437 | 1.2 (1.1 to 1.2)† | 597 | 1.1 (1.0 to 1.2)† | 840 | 1.2 (1.1 to 1.3)† | 1251 | 4.5 (4.2 to 4.9)† | 619 | 5.1 (4.6 to 5.7)† | 632 | 4.1 (3.6 to 4.5)† | |||||
1 FDR+1 SDR (excluding half siblings) | 277 | 2.2 (2.0 to 2.5)† | 156 | 2.4 (2.1 to 2.8)† | 121 | 2.0 (1.6 to 2.4)† | 253 | 7.5 (6.3 to 8.7)† | 129 | 8.3 (6.4 to 10)† | 124 | 6.9 (5.3 to 8.4)† | |||||
2 FDRs+1 SDR (excluding half siblings) | 48 | 4.8 (3.5 to 6.4)† | 37 | 5.6 (3.9 to7.7)† | 11 | 3.2 (1.6 to 5.8)† | 45 | 13 (8.6 to 17)† | 24 | 13 (7.1 to 19)† | 21 | 13 (6.3 to 19)† | |||||
≥3 FDRs+1 SDR (excluding half siblings) | 12 | 10 (5.3 to 18)† | 8 | 14 (6.0 to28)† | 4 | 6.8 (1.8 to 17)† | 11 | 26 (8.6 to 41)† | 6 | 23 (4.4 to 38)† | 5 | 26 (0 to 45) | |||||
0 FDR+2 SDRs (excluding half siblings) | 99 | 1.6 (1.3 to 1.9)† | 11 | 1.0 (0.5 to 1.7) | 88 | 1.7 (1.4 to 2.1)† | 96 | 4.2 (1.1 to 7.1)† | 43 | 7.2 (0.8 to 13)† | 53 | 1.5 (0.7 to 2.2)† | |||||
1 FDR+2 SDRs (excluding half siblings) | 32 | 5.1 (3.5 to 7.1)† | 17 | 7.5 (4.4 to 12)† | 15 | 3.7 (2.1 to 6.1)† | 32 | 6.9 (1.8 to 12)† | 18 | 5.0 (0.6 to 9.2)† | 14 | 9.3 (0 to 18) | |||||
2 FDRs+2 SDRs (excluding half siblings) | 5 | 6.7 (2.2 to 16)† | 5 | 8.2 (2.7 to 19)† | 0 | - | 5 | 6.6 (0.4 to 13)† | 3 | 8.2 (0 to 17) | 2 | 4.8 (0 to 11) | |||||
≥3 FDRs+2 SDRs (excluding half siblings) | 0 | - | 0 | - | 0 | - | 0 | - | 0 | - | 0 | - |
FDR=first degree relative; LCR=lifetime (0-79 years) cumulative risk; SDR=second degree relative; SIR=standardised incidence ratio.
Adjusted for sex, age, calendar periods, residential areas, and socioeconomic status.
Significant risks.